Bladder Cancer

With a multidisciplinary approach that includes prevention, early detection, the use of standard and promising new therapies, participation in laboratory and clinical research, and extensive complementary care, the team at Hoag Family Cancer Institute provides cancer patients with every diagnostic and therapeutic advantage.

Hoag Family Cancer Institute has been the leader in Orange County in advancing the treatment of adult patients suffering from the various hematologic malignancies, including acute leukemia’s (myeloid and lymphoid), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), Hodgkin’s Disease, Non-Hodgkin’s Lymphomas and multiple myeloma. Hoag physicians developed the first adult bone marrow transplant program in the County, and introduced the blockbuster treatment rituximab to the county in 1995, three years before it became commercially available.

For more information, call Hoag Family Cancer Institute at 949-764-5542.

Nearly all cases of bladder cancer are due to environmental causes; however, if there are multiple family members with bladder cancer (or cancer of the ureter), or if the onset was under age 40 and there is a strong family history of other early-onset cancers, then a referral for hereditary cancer risk assessment may be indicated. Genetic testing for bladder cancer is available on a research basis only.

Visit us for more details about Hoag’s Hereditary Cancer Program, including a list of frequently asked questions, or contact us at hereditarycancer@hoag.org or at 949-764-5764.